Envestnet Asset Management Inc Cellectar Biosciences, Inc. Transaction History

Envestnet Asset Management Inc

  • $281 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 07, 2021
SELL
$8.2 - $12.4 $855,956 - $1.29 Million
-104,385 Closed
0 $0
Q2 2021

Aug 04, 2021
BUY
$11.8 - $18.2 $960,590 - $1.48 Million
81,406 Added 354.26%
104,385 $124,000
Q1 2021

May 04, 2021
BUY
$15.2 - $25.0 $162,868 - $267,875
10,715 Added 87.37%
22,979 $37,000
Q4 2020

Feb 02, 2021
BUY
$11.2 - $27.7 $137,356 - $339,712
12,264 New
12,264 $26,000

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $13M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email